Françoise Puissant

Clinical Study on Embryo Transfer After Human in Vitro Fertilization

One hundred forty-six embryo transfers were carried out in the In Vitro Fertilization (IVF) Clinic at St. Pierre Hospital, Brussels, between November 1983 and February 1985. In each of these cases a series of characteristics of the replacement procedure was systematically rates indicated that (i) no significant differences appeared among three different operators, (ii) the absence or occurrence of cervical bleeding and subjective evaluation of the procedure were related to the chances of establishing a pregnancy, and (iii) the duration of replacement had no influence on the outcome of trials. A prospeative randomized study of 100 replacements showed that (i) no better pregnancy rate was obtained by placing patients in the knee-to-chest rather than the dorsal position and (ii) the addition of a rigid external sleeve to the catheter did not provide any advantage. A simplified method of replacement is thus advocated.

Use of buserelin acetate in an in vitro fertilization program: a comparison with classical clomiphene citrate-human menopausal gonadotropin treatment

A comparison has been established retrospectively between clomiphene citrate-human menopausal gonadotropin (CC-hMG) and buserelin acetate-hMG treatments in in vitro fertilization trials performed over a 3-year period. The analysis of 466 CC-hMG and 319 buserelin acetate-hMG trials shows that buserelin acetate-hMG stimulation generates a greater ovarian response resulting in higher numbers of oocytes being retrieved (6.2 + 3.8 versus 9.3 + 5.2) and fertilized (2.8 + 2.7 versus 4.3 + 3.8). More embryos are thus obtained, allowing a wider choice for intrauterine replacement and cryopreservation. Mean embryonic vitality scores do not differ (4.33 + 1.51 versus 4.44 + 1.54), implying that the embryonic quality remains similar in both treatments. A premature demise of the corpus luteum occurs in a large proportion of buserelin acetate-hMG cycles. However, when suppletive progesterone treatment is given, there is a trend toward a better implantation rate per embryo, and a significantly higher ongoing pregnancy rate is observed in relation to buserelin acetate-hMG treatment (20%) as compared with CC-hMG cycles (14%).

Higher pregnancy rates after in vitro fertilization and embryo transfer in cases with sperm defects

One hundred thirty-three couples were classified into four groups according to previous sperm analyses. These couples underwent 237 in vitro fertilization trials that led to 46 clinical pregnancies (19.4%/trial). Clinical pregnancy rate per laparoscopy of the group with male defects was significantly higher than that of the normospermic couples (25 versus 14%, P less than 0.05). The fertilization rate was significantly reduced only if two sperm anomalies were present (P less than 0.05). However, the mean number of embryos transferred did not differ significantly among the four groups, but the proportion of trials without transfer was increased with regard to the severity of sperm defect. Implantation rate per embryo in cases of triple transfer was significantly higher in the group with sperm anomalies as compared with the normospermic cases (18 versus 10%, P less than 0.02). Correction of the male problem through IVF treatment allows higher female fertility to be disclosed in these cases.

A reappraisal of perinatal mortality factors in twins

During the last 33 years, the perinatal mortality of twins has decreased regularly in our department. When examined by duration of pregnancy, mortality was lowest at 37-38 weeks. Below 38 weeks, fetal loss was paradoxically higher in twins born from multiparae. When delivery occurred beyond 38 weeks, mortality rates were increased, but only differences for primiparous group showed statistical significance. Near-term fetal loss was predominantly due to antepartal intrauterine deaths. Analysis of individual cases indicated that early termination of pregnancy might help prevent near-term stillbirths in twins delivered by primiparae. Efforts should be directed at specific detection of twins threatened by antepartum death.

Guidelines for the prevention of multiple pregnancy in treatment by in vitro fertilization.

Within the same in vitro fertilization (IVF) program, treatment trials leading to single and multiple ongoing gestation were compared. Rates of cesarean delivery, prematurity and perinatal mortality were found much higher among twin and multiple IVF pregnancies. Our work thus attempts at defining characteristics of proneness to multiple gestation in IVF treatment, in order to try and avoid its occurrence. The mean vitality score of embryos replaced is the most reliable criterion for this purpose, enabling one to replace no more than two embryos when the average score is high. Age of the patient and cause of infertility are almost nondiscriminant in this respect. Ovarian stimulation parameters such as total dosage of gonadotropin treatment and level of estrogenic response, as well as numbers of oocytes and embryos obtained, may serve as secondary criteria for assessing the twinning risk.

Sperm Vacuoles: Origin and Implications

Not before the introduction of the Nomarski differential interference contrast optics (DIC), we became aware of the presence of so-called vacuoles on the surface of the sperm head. Before the implementation of motile-sperm organelle-morphology examination (MSOME), no manuscript at all mentioned that spermatozoa free of vacuole-like structures should be selected for injection.

Use of buserelin acetate in an in vitro fertilization program: A comparison with classical clomiphene citrate‐human menopausal gonadotropin treatment

Does this high rate of failure result from inadequate technique, or does it simply reflect the maximal potential of a cohort of aspirated eggs to produce a pregnancy? And to what extent does cryopreservation affect the capacity for implantation of embryos? Methods. The study was conducted among patients enrolled in an egg-donation program. Aspirated eggs from a given cohort were distributed to the donor herself and a few recipients. The recipients were prepared by a standard protocol of hormone replacement and were assigned at random to the transfer of either fresh or frozen and thawed embryos. The donors received only fresh embryos. Results. Forty cycles of donation were, studied. In 25 cycles (63 percent) pregnancy was established in the donor, in the recipient (or recipients), or in both. Of the fresh embryos that were transferred to the recipients, 24 percent were successfully implanted, as compared with only 7.7 percent of the frozen and thawed embryos (P < 0.01). A pregnancy success rate of 37 percent of recipient cycle was observed in the recipients of fresh embryos, as compared with a rate of only 16 percent in those receiving frozen and thawed embryos (P < 0.05). Conclusions. The majority of egg cohorts evidently possess the potential to produce a pregnancy, but cryopreservation of human embryos significantly reduces their capacity for implantation.